Author:
Bernal Vicente,Sevilla Ángel,Cánovas Manuel,Iborra José L
Abstract
Abstract
The increasing commercial demand for L-carnitine has led to a multiplication of efforts to improve its production with bacteria. The use of different cell environments, such as growing, resting, permeabilized, dried, osmotically stressed, freely suspended and immobilized cells, to maintain enzymes sufficiently active for L-carnitine production is discussed in the text. The different cell states of enterobacteria, such as Escherichia coli and Proteus sp., which can be used to produce L-carnitine from crotonobetaine or D-carnitine as substrate, are analyzed. Moreover, the combined application of both bioprocess and metabolic engineering has allowed a deeper understanding of the main factors controlling the production process, such as energy depletion and the alteration of the acetyl-CoA/CoA ratio which are coupled to the end of the biotransformation. Furthermore, the profiles of key central metabolic activities such as the TCA cycle, the glyoxylate shunt and the acetate metabolism are seen to be closely interrelated and affect the biotransformation efficiency. Although genetically modified strains have been obtained, new strain improvement strategies are still needed, especially in Escherichia coli as a model organism for molecular biology studies. This review aims to summarize and update the state of the art in L-carnitine production using E. coli and Proteus sp, emphasizing the importance of proper reactor design and operation strategies, together with metabolic engineering aspects and the need for feed-back between wet and in silico work to optimize this biotransformation.
Publisher
Springer Science and Business Media LLC
Subject
Applied Microbiology and Biotechnology,Bioengineering,Biotechnology
Reference108 articles.
1. Löster H: Carnitine and cardiovascular diseases. 2003, Bochum: Ponte Press Verlags GmbH
2. Naidu GSN, Lee IY, Lee EG, Kang GH, Park YH: Microbial and enzymatic production of L-carnitine. Bioprocess Eng. 2000, 23: 627-635. 10.1007/s004490000212.
3. Seim H, Eichler K, Kleber HP: L-carnitine and its precursor, γ-butyrobetaine. Nutraceuticals in Health and Disease Prevention. Edited by: Kramer K, Hoppe PP, Packer L. 2001, New York: Marcel Dekker, Inc, 217-256.
4. Kleber HP: Bacterial carnitine metabolism. FEMS Microbiol Lett. 1997, 147: 1-9. 10.1111/j.1574-6968.1997.tb10212.x.
5. Jung H, Jung K, Kleber HP: L(-)-carnitine uptake by Escherichia coli. J Basic Microbiol. 1990, 30: 507-514. 10.1002/jobm.3620300711.
Cited by
34 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献